Ivy Institute of Stem Cells Co. Ltd Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02442037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now